• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• Twitter
• Newsletter

Advertisement

Organisation › Details

ImaBiotech Corporation

ImaBiotech is a Contract Research Organization (CRO) with facilities in Boston (MA, USA) and Lille (Eurasanté Parc, France). The company offers innovative services and software to the pharmaceutical research sector, providing highly in vivo informative drug efficacy and toxicity evaluations during preclinical and clinical stage developments at cellular level, making better and safer drugs. Services are based on histology combined to label free molecular imaging (Quantitative Mass Spectrometry Imaging, QMSI) a technology developed and constantly improved by ImaBiotech. QMSI is a game changer for the pharmaceutical industry in all therapeutic areas. While other techniques provide global information, this molecular technique provides a deeper understanding of a drugs localization and its pharmacological effects at cellular level. This improves the interpretation of drug efficacy and toxicity, resulting in better drugs and decreasing time-to-market. *

 

	Start	2016-03-21 existent
	Group	ImaBiotech (Group)
	Industry	mass spectrometry software (MS software)
	Industry 2	Quantinetix™ software for quantitative MALDI imaging
	Region	Cambridge, MA
	Country	United States (USA)
	Street	185 Alewife Brook Parkway
	City	02138 Cambridge, MA
	Tel	+1-857-777-6764
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for �About Section�: ImaBiotech S.A.S.. (1/17/19). "Press Release: OCR and ImaBiotech Initiate a Strategic Partnership to Provide in situ Drug Efficacy and Target Exposure Services in Pets with Naturally Occuring Tumors". Lille.
		Record changed: 2019-07-13

Advertisement

More documents for ImaBiotech (Group)

• [1] ImaBiotech S.A.S.. (1/17/19). "Press Release: OCR and ImaBiotech Initiate a Strategic Partnership to Provide in situ Drug Efficacy and Target Exposure Services in Pets with Naturally Occuring Tumors". Lille....
• [2] ImaBiotech S.A.S.. (1/17/19). "Press Release: Metabrain Research and ImaBiotech Initiate a Strategic Partnership to Offer Cuttingedge Preclinical Research Services in Metabolic Disorders". Lille....
• [3] ImaBiotech S.A.S.. (6/13/16). "Press Release: Mass Spectrometry Imaging (MSI) Award 2016". Lille....
• [4] ImaBiotech S.A.S.. (4/14/16). "Press Release: ImaBiotech Signs License Agreement with Lawrence Berkeley National Laboratory". Lille & Berkeley, CA....
• [5] ImaBiotech S.A.S.. (3/29/16). "Press Release: ImaBiotech’s First Worldwide Patent Has Been Granted for Its Quantification Innovation in MSI". Lille....
• [6] ImaBiotech S.A.S.. (3/16). "Press Release: Imabiotech Obtain 6M€ for a New European Project in Partnership with Lille I University and Cubic Pharmaceuticals"....
• [7] ImaBiotech S.A.S.. (12/1/15). "Press Release: ImaBiotech’s Multimaging Technology Chosen by Dermira for Its Skin Disposition Study". Lille....
• [8] ImaBiotech S.A.S.. (11/10/15). "Press Release: Galderma and ImaBiotech Develop a Long-term Alliance to Access Multimaging Services". Lille & Sophia Antipolis....
• [9] ImaBiotech S.A.S.. (5/15). "Press Release: ImaBiotech to Conduct Pilot Study with GSK to Assess ImaBiotech's Multimaging Technology". Lille....
• [10] ImaBiotech S.A.S.. (4/6/15). "Press Release: Iteos and ImaBiotech Awarded Grant for Tumor Microenvironment Characterization and Applications in Immuno-oncology". Gosselies & Loos....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2022. Made in Germany.